BWV Blue Water Vaccines Inc

4,377

$0.2455

$0.0245

(9.07%)

Today

Market Cap	$4.37M
Volume (M)	402.00
52-Wk High	$1.95
52-Wk Low	$0.1809

ST Data

Watchers

New Watcher Rank

Fundamentals

Blue Water Biotech Signs Non-Binding Term Sheet to Acquire a Commercial Stage Oncology CompanyGlobe Newswire • about 1 month ago

Transaction will Advance Company's Shift in Business Strategy Aligned with Life Sciences Industry Expertise of New Leadership TeamCINCINNATI, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech...

Share to Feed

Blue Water Biotech Announces It Has Regained Compliance with Nasdaq Listing Rule 5250(c)(1)Globe Newswire • about 1 month ago

CINCINNATI, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (Nasdaq: BWV) ("BWB" or the Company ) today announced that it has received a letter from the Nasdaq Stock Market, LLC...

Blue Water Biotech Issues Letter to ShareholdersGlobe Newswire • about 1 month ago

CINCINNATI, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (Nasdaq: BWV) ("BWB" or the Company ) today issued the following shareholder letter from the Company's Chief Executive...

Blue Water Biotech Appoints Dr. Neil J. Campbell as President and CEO and Bruce Harmon as CFOGlobe Newswire • about 2 months ago

Veteran Life Sciences Executives Bring Extensive Public Company Operating Experience to Leadership TeamCINCINNATI, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (Nasdaq: BWV), which is...

Blue Water Biotech and Copay Consultants Collaborate to Build Copay Assistance Programs for Blue Water's Commercial ProductsGlobe Newswire • 4 months ago

CINCINNATI, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (Blue Water or the Company), a biotechnology and pharmaceutical company spanning multiple sectors, today announced the signing of an agreement with Copay Consultants, LLC (Copay Consultants) to build copay assistance programs for...

Blue Water Biotech Announces Closing of Warrant Exercise and Issuance of New Warrants in A Private Placement For $2.7 Million Gross ProceedsGlobe Newswire • 4 months ago

CINCINNATI, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (Blue Water or the Company) (Nasdaq: BWV), today announced the closing of its previously announced exercise of certain existing warrants to purchase 2,486,214 shares of its common stock at a reduced exercise price of $1.09 per ...

Blue Water Biotech Announces Exercise of Warrants and Issuance of New Warrants in A Private Placement For $2.7 Million Gross ProceedsGlobe Newswire • 4 months ago

CINCINNATI, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. ("Blue Water" or the Company) (Nasdaq: BWV), today announced it has entered into a definitive agreement for the exercise of certain existing warrants to purchase 2,486,214 shares of its common stock at a reduced exercise price of...

Blue Water Biotech and Knipper Health Join Forces to Distribute Samples for ENTADFI(R) and ZONTIVITY(R) to PhysiciansGlobe Newswire • 4 months ago

CINCINNATI, July 31, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (Blue Water or the Company) (Nasdaq: BWV), a biotechnology and pharmaceutical company focused on developing and commercializing transformational therapies to address significant health challenges globally, today announced an ...

Blue Water Biotech Teams with UpScriptHealth to Launch Telemedicine Platform for Benign Prostatic Hyperplasia Asset, ENTADFI(R)Globe Newswire • 5 months ago

CINCINNATI, July 25, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (Blue Water or the Company) (Nasdaq: BWV), a biotechnology and pharmaceutical company focused on developing and commercializing transformational therapies to address significant health challenges globally, today announced an ...

Blue Water Biotech Issues CEO Shareholder Letter Providing Update on Commercial Launch ActivitiesGlobe Newswire • 5 months ago

CINCINNATI, July 17, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (Blue Water or the Company) (Nasdaq: BWV), a biotechnology and pharmaceutical company focused on developing and commercializing transformational therapies to address significant health challenges globally, today issued the ...